Impact of hepatitis c virological load and bilharzial antibodies on rapid virological response

Viral kinetic changes after 4 weeks and its relation to response to Peg. INF therapy in chronic HCV genotype 4 patients

Viral co-infections in chronic hepatitis C virus patients

Correlation between lipid profile and rapid virological response to treatment of hepatitis C virus genotype IV with pegylated interferon alpha and ribavirin

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Fluvastatin as an adjuvant therapy with pegylated Interferon and Ribavirin in the treatment of chronic hepatitis C virus

Aetiology of anemia in chronic HCV patients receiving pegylated interferon plus ribavirin

Changes in chemokines levels in relation to combined interferon and ribavirin therapy in Egyptian patients with chronic hepatitis C

Changes in immunomodulators in relation to interferon therapy in hepatitis c virus infection